How could this be: A 100-year-old government consulting firm that’s always taken its marching orders from Uncle Sam, investing its own money in the big ideas of the underfunded?
It actually makes perfect sense, said Karen Dahut, Booz Allen’s executive vice president who leads the company’s strategic innovation group. And it’s just one possibility that might come of the company’s partnership with downtown technology startup hub 1776 announced Monday.
Earlier this month, President Obama announced his 2015 budget, a roadmap for accelerating economic growth, expanding opportunity for all Americans and ensuring fiscal responsibility. The budget supports the President’s Management Agenda to deliver a 21st century government that is more effective, efficient, and supportive of economic growth. One key element of the President’s Management Agenda is accelerating the transfer of Federally funded research from the laboratory to the commercial marketplace – a “Lab-to-Market” agenda.
The Federal Government spends more than $130 billion on research and development (R&D) each year, conducted primarily at universities and Federal laboratories. This investment supports fundamental research that expands the frontiers of human knowledge, and yields extraordinary long-term economic impact through the creation of new knowledge and ultimately new industries – often in unexpected ways.
In the latest test of 3D printing in orthopedic surgery, neurosurgeons in The Netherlands announced that they successfully implanted a 3D printer skull to treat a 22-year old woman suffering from a bone disorder.
The procedure, carried out by surgeons at University Medical Center Utrecht, was carried out three months ago but was only disclosed after ensuring that the implant wasn’t rejected and the patient made a full recovery. Australian company Anatomics produced the 3-D skull implant.
San Francisco’s SoMa neighborhood; Cambridge, Massachusetts’ Kendall Square; Lower Manhattan: These are the dense, walkable neighborhoods that have become the new hubs of America’s tech scene, as the center of gravity for venture investment and start-up activity shifts from suburbs to urban centers.
This urban shift in America’s venture capital-fueled innovation economy is detailed in my latest report from the Martin Prosperity Institute, released today at The Atlantic’s Start-Up City: Miami event. (The report builds upon and deepens the analysis developed initially in my Start-Up City series here on the site last year).
Reading the cover story of last week’s Capital Business (“Educating tomorrow’s entrepreneurs”) echoed what I had seen at the recent South by Southwest Edu conference, where I took part in a panel called “Student Startups: The Ultimate Educational Experience.”
I was intrigued when I realized the audience for the panel was nearly 75 percent K-12 educators — not the higher ed audience I and the other panelists were expecting. Maybe I shouldn’t have been so surprised. The piqued interest for primary and secondary educators is exciting and encouraging, especially from where I sit.
The University of Maryland kicked off today its third annual 30 Days of EnTERPreneurship, a month-long celebration of the university’s fearless ideas, innovation and impact.
“The University of Maryland has long been a pioneer in entrepreneurship and a leader in research and academic innovation. And in recent years, the university has put even greater, campus-wide emphasis on preparing faculty, students and staff to tackle the world’s toughest problems through innovation and entrepreneurship. Our ’30 Days of EnTERPreneurship’ highlights and celebrates that commitment across all schools,” says Dean Chang, UMD’s associate vice president for innovation and entrepreneurship.
Cardiovascular disease accounts for 52% of female deaths and 42% of male deaths in the EU. Approximately four million people in Europe and 1.9 million people in the EU die of cardiovascular disease each year, according to the European Society of Cardiology. Cardiovascular disease and strokes are usually caused by high levels of bad cholesterol, high blood pressure, obesity, unhealthy diet and physical inactivity.
The European Society for Cardiology (ESC) and the European Heart Network (EHN) estimate the cost to the EU economy at over €196 billion per year, with healthcare expenditure varying from 4% in Luxembourg to 17% in Estonia, Latvia and Poland.
RuiYi, Inc. announced today a $15 million Series B financing by existing investors: 5AM Ventures, Versant Ventures, Apposite Capital, SR One, the independent corporate healthcare venture capital fund of GlaxoSmithKline, Merck Serono Ventures, the strategic corporate venture fund of Merck Serono, and Aravis SA. RuiYi has a pipeline of innovative monoclonal antibodies to previously untargeted G protein coupled receptors (GPCRs) for important global, therapeutic needs. The financing will support the continued development of RuiYi’s lead asset, RYI-008, a novel anti-IL-6 monoclonal antibody (mAb), and the discovery and development of new therapeutic mAbs targeting GPCRs, including a first-in-class mAb to cannabinoid receptor 1 (CB-1), a commercially validated but previously intractable drug target. In addition, RuiYi expanded the leadership team, appointing Erik Karrer, Ph.D. as chief scientific officer and Brian Campion, Ph.D. as vice president of business development.
Doctors and Life Science Professionals: Invest in what you know!
Wednesday, April 9, 2014 from 6:00 PM to 8:30 PM
The original idea for the subtitle of this meeting was “doctors don’t have to be bad investors!” Doctors have the resources to invest, but often lack the time or expertise needed to evaluate investment opportunities.
However, with healthcare now the fastest growing sector of the economy, physicians are uniquely positioned to use their knowledge to invest wisely and achieve great returns. Additionally, with all the recent SEC changes, new approaches to investing, such as crowd equity, bring opportunities to take part in investing like never before. Therefore, for doctors, it starts with investing in what you know!
The National Science Foundation (NSF) announced a new round of funding for the Innovation Corps Sites (I-Corps Sites) Program. Housed at institutions of higher education, I-Corps Sites are intended to:
